The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 27, 2015

Filed:

Sep. 24, 2014
Applicant:

Isogenis, Inc., Aurora, CO (US);

Inventors:

Miles B. Brennan, Denver, CO (US);

Erin K. Spiegel, Aurora, CO (US);

Uwe D. Staerz, Denver, CO (US);

Charles Wall, Littleton, CO (US);

Janae Wheeler, Brighton, CO (US);

William J. Maslanik, Denver, CO (US);

Xianghua Zhang, Auroroa, CO (US);

Assignee:

Isogenis, Inc., Aurora, CO (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/861 (2006.01); C12N 15/00 (2006.01); C12N 15/86 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); C12N 7/00 (2013.01); C12N 2710/10043 (2013.01); C12N 2710/10052 (2013.01); C12N 2710/10343 (2013.01); C12N 2710/10352 (2013.01);
Abstract

The embodiments disclosed herein relate to the construction of fully-deleted Adenovirus-based gene delivery vectors packaged without helper Adenovirus, and more particularly to their use in gene therapy for gene and protein expression, vaccine development, and immunosuppressive therapy for allogeneic transplantation. In an embodiment, a method for propagating an adenoviral vector includes (a) providing an Adenovirus packaging cell line; (b) transfecting a fully-deleted Adenoviral vector construct into the cell line; and optionally (c) transfecting a packaging construct into the cell line, wherein the fully-deleted Adenoviral vector construct and optionally the packaging construct can transfect the Adenovirus packaging cell line resulting in the encapsidation of a fully-deleted Adenoviral vector independent of helper Adenovirus. In an embodiment, a target cell is transduced with the encapsidated fully-deleted Adenoviral vector for treating a condition, disease or a disorder.


Find Patent Forward Citations

Loading…